Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19

BACKGROUND: Many treatments are being assessed for repurposing to treat coronavirus disease 2019 (COVID-19). One drug that has shown promising results in vitro is nitazoxanide. Unlike other postulated drugs, nitazoxanide shows a high ratio of maximum plasma concentration (C(max)), after 1 day of 500...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Virus Erad
Hlavní autoři: Pepperrell, Toby, Pilkington, Victoria, Owen, Andrew, Wang, Junzheng, Hill, Andrew M
Médium: Artigo
Jazyk:Inglês
Vydáno: Mediscript Ltd 2020
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7332204/
https://ncbi.nlm.nih.gov/pubmed/32405422
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky